Phase-III

Sputnik’s single-dose vax gets DCGI nod for Phase-III trials in India

The nod comes after a recent study published in the medical journal The Lancet said that Sputnik Light showed 78.6 to 83.7 per cent efficacy against Covid-19, significantly higher than most two-shot...